Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Bostrom BC, Sensel MR, Sather HN, Gaynon PS, La MK, Johnston K, Erdmann GR, Gold S, Heerema NA, Hutchinson RJ, Provisor AJ, Trigg ME; Children's Cancer Group. Bostrom BC, et al. Blood. 2003 May 15;101(10):3809-17. doi: 10.1182/blood-2002-08-2454. Epub 2003 Jan 16. Blood. 2003. PMID: 12531809 Free article. Clinical Trial.
A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
Bell BA, Brockway GN, Shuster JJ, Erdmann G, Sterikoff S, Bostrom B, Camitta BM; Pediatric Oncology Group study (now The Children's Oncology Group). Bell BA, et al. Among authors: bostrom b. Pediatr Blood Cancer. 2004 Aug;43(2):105-9. doi: 10.1002/pbc.20089. Pediatr Blood Cancer. 2004. PMID: 15236274 Clinical Trial.
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study.
Lowe ES, Kitchen BJ, Erdmann G, Stork LC, Bostrom BC, Hutchinson R, Holcenberg J, Reaman GH, Woods W, Franklin J, Widemann BC, Balis FM, Murphy RF, Adamson PC. Lowe ES, et al. Among authors: bostrom bc. Cancer Chemother Pharmacol. 2001 Mar;47(3):199-205. doi: 10.1007/s002800000229. Cancer Chemother Pharmacol. 2001. PMID: 11320662 Free article.
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Jacobs SS, Stork LC, Bostrom BC, Hutchinson R, Holcenberg J, Reaman GH, Erdmann G, Franklin J, Neglia JP, Steinberg SM, Balis FM, Adamson PC; Children's Oncology Group; National Cancer Institute. Jacobs SS, et al. Pediatr Blood Cancer. 2007 Sep;49(3):250-5. doi: 10.1002/pbc.20964. Pediatr Blood Cancer. 2007. PMID: 16856155 Clinical Trial.
191 results